The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 357.50
Bid: 350.00
Ask: 365.00
Change: 6.00 (1.69%)
Spread: 15.00 (4.286%)
Open: 357.50
High: 360.00
Low: 360.00
Prev. Close: 354.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Dealings

23 Nov 2017 10:21

RNS Number : 3533X
Focusrite PLC
23 November 2017
 

Focusrite Plc

 

("the Company" or "the Group")

 

Directors' Dealings

Grant of Share Options to Directors

 

Focusrite Plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 22 November 2017 it issued 126,240 options under the Company's Performance Share Plan to Tim Carroll, CEO of the Company and Jeremy Wilson, CFO of the Company as listed below. The awards have a vesting date of 22 November 2020.

 

Director

Options granted

Tim Carroll

70,176

Jeremy Wilson

56,064

 

The performance measurement period is from 1 September 2017 to 31 August 2020 and the awards will vest subject to the rules of the Focusrite Plc Performance Share Plan and the Remuneration Committee's determination of the extent to which the performance conditions applicable to the award have been satisfied. Full details of these performance conditions are set out in the Company's Directors' Remuneration Report for the year ending 31 August 2017. Vested awards are exercisable until the tenth anniversary of the grant date, subject to the individual's ongoing employment.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

1. Tim Carroll

3. Jeremy Wilson

2

Reason for the notification

a)

Position/status

 Directors of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Option over Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

Grant of options pursuant to the Focusrite Plc Performance Share Plan

c)

Price(s) and volume(s)

 

Exercise Prices per share

Volumes

1. 0.1p

2. 0.1p

1. 70,176

2. 56,064

 

d)

Aggregated information

- Aggregated volume 

- Price 

Weighted average exercise price: 0.1p per share

Aggregated volume: 126,240

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

Outside a trading venue

 

 

-ends-

 

 

Enquiries:

 

Focusrite Plc:

 

Phil Dudderidge (Executive Chairman)

+44 1494 462246

Jeremy Wilson (CFO)

+44 1494 462246

 

 

Panmure Gordon

 

Freddy Crossley

+44 20 7886 2968

Tom Salvesen

+44 20 7886 2904

 

 

Belvedere Communications

 

John West

+44 20 3567 0510

Kim van Beeck

+44 20 3567 0510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKNDDKBDDFDB
Date   Source Headline
13th Sep 20177:00 amRNSTrading Update
31st Aug 20177:00 amRNSTR-1: Notification of major holdings
19th May 20173:40 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSHalf Year Results for the period ended 28 Feb 2017
20th Mar 20177:00 amRNSTrading Update
24th Feb 20173:56 pmRNSPDMR Grant of Share Options
10th Jan 20172:46 pmRNSResult of AGM
10th Jan 20177:00 amRNSAGM Statement
7th Dec 20164:28 pmRNSTR-1: Notification of Major Interest in Shares
6th Dec 201611:00 amRNSAnalyst and Investor Day
5th Dec 20163:13 pmRNSDirector/PDMR Shareholding
5th Dec 20167:00 amRNSAppointment of Chief Executive Officer
24th Nov 20165:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20166:15 pmRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSFinal Results for the Year Ended 31 August 2016
6th Oct 20167:00 amRNSFurther Expansion into Asia
14th Sep 20167:00 amRNSPre-close Trading Update
19th Jul 20167:00 amRNSBoard Change
2nd Jun 20167:00 amRNSMajor New Product Upgrade and Launch
6th May 20162:56 pmRNSHolding(s) in Company & Total Voting Rights
26th Apr 20167:00 amRNSHalf Year Results
19th Apr 20169:22 amRNSNotice of Interim Results
14th Mar 20167:00 amRNSTrading Update
29th Jan 20163:34 pmRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement and Update on Trading
9th Dec 20157:00 amRNSResults for the year ended 31 August 2015
23rd Nov 20157:00 amRNSNotice of Preliminary Results
15th Sep 20157:00 amRNSPre-close Trading Update
6th May 20157:01 amRNSDividend Timetable
29th Apr 20157:00 amRNSHalf Year Results for the period ended 28 Feb 2015
18th Mar 20157:00 amRNSQ1 products and news update
12th Mar 20157:00 amRNSTrading Update
12th Dec 20145:37 pmRNSTR-1: Notification of Major Interest in Shares
11th Dec 20147:00 amRNSAdmission to AIM and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.